COVID-19 Monoclonal Antibodies: Feasible Mechanisms for Generating Needed Evidence

Feasible Mechanisms for Generating Needed Evidence Cover

COVID-19 Monoclonal Antibodies: Feasible Mechanisms for Generating Needed Evidence

Published date

December 10, 2020

Duke-Margolis Affiliated Authors

morgan romine

Morgan Romine, MPA

Chief of Staff
Senior Team Member

Marta Wosinska

Marta WosiƄska, PhD

Consulting Professor, Fuqua School of Business
Deputy Director, Policy, Duke-Margolis Center for Health Policy
Margolis Core Faculty

Kroetsch

Adam Kroetsch, MPP

Research Director, Biomedical Innovation and Regulatory Policy
Senior Team Member

Photo of Anna Zavodszky

Anna Zavodszky

Research Assistant

Mark McClellan

Mark McClellan, MD, PhD

Director of Margolis Center
Robert J. Margolis, MD, Professor of Business, Medicine and Policy
Margolis Executive Core Faculty